Myriad Genetics and SimonMed® Imaging Collaborate to Advance Precision Medicine with New Genetic Risk Assessment Program

(marketscreener.com) New program will increase access to affordable genetic testing while also helping to identify and elevate high-risk patient careSALT LAKE CITY, April 12, 2023 -- Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, and SimonMed® Imaging, one of the largest independent outpatient medical imaging providers and...https://www.marketscreener.com/quote/stock/MYRIAD-GENETICS-INC-10141/news/Myriad-Genetics-and-SimonMed-Imaging-Collaborate-to-Advance-Precision-Medicine-with-New-Genetic-Ris-43475719/?utm_medium=RSS&utm_content=20230412